ArticleScientific reports2024
Development of risk models for early detection and prediction of chronic kidney disease in clinical settings.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.Clinical kidney journal · 2026Review
- A Risk-Oriented and Explainable Hierarchical AI Framework for Chronic Kidney Disease Classification.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) imposes a high burden with high mortality and morbidity rates. Early detection of CKD is imperative in preventing the adverse outcomes attributed to the later stages. Therefore, this study aims to utilize machine learning techniques to predict CKD at early stages. This study uses data obtained from a large longitudinal cohort study. The features include patients' sociodemographic, anthropometric, and laboratory tests that are mostly associated with CKD based on national and international studies. Missing data and outliers were deleted using listwise and interquartile range techniques, respectively. Data initially remained imbalanced to investigate the ability of models to work on imbalanced datasets. Stratified K-folds cross-validation, a robust approach that performs well on imbalanced data, was further performed to enhance the splitting. Interestingly, an interaction was found between age and gender where contrasting data was generated, therefore, to avoid this interaction gender-specific algorithms were developed. Four main algorithms and four algorithms using the stratified K-folds cross-validation technique, consisting of gender-specific Random Forest and feedforward Neural Networks were developed using the preprocessed data of 6855 participants. The RF model in women exhibited the highest AUC of 0.90 followed closely by 0.89 in their NN model. Both models constructed for men yielded an AUC of 0.88. Sensitivity scores were higher in men compared to women. Models demonstrated subpar results regarding specificity, however, the high precision and F1 scores, make the models extremely valuable in a clinical setting to accurately identify CKD cases while minimizing false positive diagnoses. Moreover, the results from stratified K-fold cross-validation indicated that the NN models were more sensitive to the imbalanced dataset and demonstrated a marked increase in performance, particularly specificity, after this approach. These data offer valuable insights for the development of future risk stratification models for CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.